Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

The cleavage of host cell proteins by HIV-1 protease.

Snásel J, Pichová I.

Folia Biol (Praha). 1996;42(5):227-30. Review. No abstract available.

PMID:
8997639
2.

Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease.

Höner B, Shoeman RL, Traub P.

Cell Biol Int Rep. 1992 Jul;16(7):603-12.

PMID:
1516138
3.

Support Vector Machines for predicting HIV protease cleavage sites in protein.

Cai YD, Liu XJ, Xu XB, Chou KC.

J Comput Chem. 2002 Jan 30;23(2):267-74.

PMID:
11924738
4.

HIVcleave: a web-server for predicting human immunodeficiency virus protease cleavage sites in proteins.

Shen HB, Chou KC.

Anal Biochem. 2008 Apr 15;375(2):388-90. doi: 10.1016/j.ab.2008.01.012. Epub 2008 Jan 15.

PMID:
18249180
5.

Computational proteomics analysis of HIV-1 protease interactome.

Kontijevskis A, Wikberg JE, Komorowski J.

Proteins. 2007 Jul 1;68(1):305-12.

PMID:
17427231
6.

Defining HIV-1 protease substrate selectivity.

Beck ZQ, Morris GM, Elder JH.

Curr Drug Targets Infect Disord. 2002 Mar;2(1):37-50. Review.

PMID:
12462152
7.

Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.

Zhang YM, Imamichi H, Imamichi T, Lane HC, Falloon J, Vasudevachari MB, Salzman NP.

J Virol. 1997 Sep;71(9):6662-70.

8.
9.

Specificity rule discovery in HIV-1 protease cleavage site analysis.

Kim H, Zhang Y, Heo YS, Oh HB, Chen SS.

Comput Biol Chem. 2008 Feb;32(1):71-8. Epub 2007 Sep 29.

PMID:
18006382
10.

HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation.

Nie Z, Phenix BN, Lum JJ, Alam A, Lynch DH, Beckett B, Krammer PH, Sekaly RP, Badley AD.

Cell Death Differ. 2002 Nov;9(11):1172-84.

11.

In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system.

Ohlmann T, Prévôt D, Décimo D, Roux F, Garin J, Morley SJ, Darlix JL.

J Mol Biol. 2002 Apr 19;318(1):9-20.

PMID:
12054764
12.

Local and spatial factors determining HIV-1 protease substrate recognition.

Hazebrouck S, Machtelinckx-Delmas V, Kupiec JJ, Sonigo P.

Biochem J. 2001 Sep 1;358(Pt 2):505-10.

13.

HIV-1 protease cleavage site prediction based on amino acid property.

Niu B, Lu L, Liu L, Gu TH, Feng KY, Lu WC, Cai YD.

J Comput Chem. 2009 Jan 15;30(1):33-9. doi: 10.1002/jcc.21024.

PMID:
18496789
14.

Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.

Lin YC, Beck Z, Lee T, Le VD, Morris GM, Olson AJ, Wong CH, Elder JH.

J Virol. 2000 May;74(10):4710-20.

15.

Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.

Chellappan S, Kairys V, Fernandes MX, Schiffer C, Gilson MK.

Proteins. 2007 Aug 1;68(2):561-7.

PMID:
17474129
16.
17.

Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.

Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM.

Virology. 2002 Jan 5;292(1):137-49.

18.

HIV protease: enzyme function and drug resistance.

Gulnik S, Erickson JW, Xie D.

Vitam Horm. 2000;58:213-56. Review.

PMID:
10668400
20.

X-ray structure of HIV-1 protease in situ product complex.

Bihani S, Das A, Prashar V, Ferrer JL, Hosur MV.

Proteins. 2009 Feb 15;74(3):594-602. doi: 10.1002/prot.22174.

PMID:
18704947

Supplemental Content

Support Center